News

Renesas Electronics Corporation has introduced the RA2T1 microcontroller (MCU) group based on the Arm Cortex-M23 processor optimized for motor control systems. RA2T1 devices are specifically designed ...
Renesas Electronics Corporation has introduced the RA2T1 MCU group, based on the Arm Cortex-M23 processor, optimised for motor control systems. RA2T1 devices are specifically designed for single-motor ...
Despite the extensive use of EC motors, brushed motors haven’t been relegated to just ultra-low-end applications such as ...
UCB and Biogen say their first phase 3 trial of systemic lupus erythematosus (SLE) candidate dapirolizumab pegol was a success, with a second planned.
Johnson & Johnson has moved a step closer to filing a potential first-in-class therapy for psoriasis after the drug hit the mark in a phase 3 trial.